Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up')

Francesco Cellini; Stefania Manfrida; Maria Antonietta Gambacorta; Vincenzo Valentini

doi:10.1016/j.annonc.2023.03.003

Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up')

Francesco Cellini
, Stefania Manfrida
, Maria Antonietta Gambacorta
, Vincenzo Valentini

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

inglese

Lingua originale	Inglese
pagine (da-a)	N/A-N/A
Rivista	Annals of Oncology
DOI	https://doi.org/10.1016/j.annonc.2023.03.003
Stato di pubblicazione	Pubblicato - 2023

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Neoadjuvant

Accesso al documento

10.1016/j.annonc.2023.03.003

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint

Entra nei temi di ricerca di 'Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up')'. Insieme formano una fingerprint unica.

Cita questo

Cellini, F., Manfrida, S., Gambacorta, M. A., & Valentini, V. (2023). Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up'). Annals of Oncology, N/A-N/A. https://doi.org/10.1016/j.annonc.2023.03.003

Cellini, Francesco ; Manfrida, Stefania ; Gambacorta, Maria Antonietta et al. / Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up'). In: Annals of Oncology. 2023 ; pagg. N/A-N/A.

@article{2b050bf226d24d33bf42e8697f3b028f,

title = "Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up')",

abstract = "inglese",

keywords = "Neoadjuvant, Neoadjuvant",

author = "Francesco Cellini and Stefania Manfrida and Gambacorta, \{Maria Antonietta\} and Vincenzo Valentini",

year = "2023",

doi = "10.1016/j.annonc.2023.03.003",

language = "English",

pages = "N/A--N/A",

journal = "Annals of Oncology",

issn = "1569-8041",

publisher = "Elsevier Ltd",

}

Cellini, F, Manfrida, S, Gambacorta, MA & Valentini, V 2023, 'Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up')', Annals of Oncology, pagg. N/A-N/A. https://doi.org/10.1016/j.annonc.2023.03.003

Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up'). / Cellini, Francesco; Manfrida, Stefania; Gambacorta, Maria Antonietta et al.
In: Annals of Oncology, 2023, pag. N/A-N/A.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up')

AU - Cellini, Francesco

AU - Manfrida, Stefania

AU - Gambacorta, Maria Antonietta

AU - Valentini, Vincenzo

PY - 2023

Y1 - 2023

N2 - inglese

AB - inglese

KW - Neoadjuvant

UR - http://hdl.handle.net/10807/235170

U2 - 10.1016/j.annonc.2023.03.003

DO - 10.1016/j.annonc.2023.03.003

M3 - Article

SN - 1569-8041

SP - N/A-N/A

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Cellini F, Manfrida S, Gambacorta MA, Valentini V. Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up'). Annals of Oncology. 2023;N/A-N/A. doi: 10.1016/j.annonc.2023.03.003